Skip to main content

TSE:CRH - CRH Medical Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: C$5.05
  • Forecasted Upside:
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
C$0.00
+0.30 (1.20%)
1 month | 3 months | 12 months
Get New CRH Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CRH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CRH

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
C$5.05
▲ +∞ Upside Potential
This price target is based on 2 analysts offering 12 month price targets for CRH Medical in the last 3 months. The average price target is C$5.05, with a high forecast of C$5.10 and a low forecast of C$5.00. The average price target represents a ∞ upside from the last price of C$0.00.

Hold

The current consensus among 2 polled investment analysts is to hold stock in CRH Medical. This rating has held steady since January 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/23/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/21/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
5/21/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
8/19/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
11/17/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
2/15/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
4/16/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/16/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/9/2021National Bank FinancialDowngradeOutperform ➝ TenderC$4.25 ➝ C$5.10
i
2/9/2021Royal Bank of CanadaDowngradeOutperform ➝ Sector PerformC$4.00 ➝ C$5.00
i
12/24/2020Royal Bank of CanadaLower Price TargetC$4.50 ➝ C$4.00
i
12/23/2020Bloom BurtonDowngradeBuy ➝ Hold
i
Rating by D. Martin at Bloom Burton
8/12/2020Bloom BurtonReiterated RatingBuy
i
Rating by D. Martin at Bloom Burton
5/14/2020Beacon SecuritiesDowngradeBuy ➝ Hold
i
Rating by D. Cooper at Beacon Securities
5/4/2020National Bank FinancialLower Price TargetOutperformC$4.25 ➝ C$4.00
i
3/13/2020Royal Bank of CanadaLower Price TargetOutperformC$6.50 ➝ C$4.75
i
3/5/2020National Bank FinancialLower Price TargetC$6.25 ➝ C$5.50
i
2/5/2020Royal Bank of CanadaBoost Price TargetOutperformC$5.50 ➝ C$6.50
i
2/3/2020National Bank FinancialBoost Price TargetOutperformC$5.75 ➝ C$6.25
i
8/1/2019Bloom BurtonUpgradeAccumulate ➝ Buy
i
Rating by D. Martin at Bloom Burton
3/20/2019Clarus SecuritiesReiterated RatingBuy
i
Rating by N. Atkinson at Clarus Securities
3/15/2019Acumen CapitalLower Price TargetC$6.25 ➝ C$6.00
i
1/9/2019TD SecuritiesLower Price TargetBuyC$6.50 ➝ C$5.50
i
9/5/2018TD SecuritiesBoost Price TargetBuyC$5.50 ➝ C$6.50
i
9/5/2018Royal Bank of CanadaBoost Price TargetOutperformC$5.00 ➝ C$5.50
i
8/21/2018National Bank FinancialBoost Price TargetOutperformC$5.00 ➝ C$5.75
i
8/3/2018TD SecuritiesBoost Price TargetBuyC$5.00 ➝ C$5.50
i
8/3/2018Royal Bank of CanadaBoost Price TargetOutperformC$4.75 ➝ C$5.00
i
7/27/2018TD SecuritiesUpgradeHold ➝ BuyC$4.00 ➝ C$5.00
i
5/2/2018TD SecuritiesBoost Price TargetHoldC$3.50 ➝ C$4.00
i
5/2/2018Royal Bank of CanadaBoost Price TargetOutperformC$4.50 ➝ C$4.75
i
5/1/2018National Bank FinancialBoost Price TargetOutperformC$4.50 ➝ C$5.00
i
3/7/2018TD SecuritiesBoost Price TargetHoldC$2.50 ➝ C$3.50
i
3/6/2018National Bank FinancialBoost Price TargetOutperformC$4.25 ➝ C$4.50
i
11/6/2017National Bank FinancialLower Price TargetOutperformC$5.25 ➝ C$4.25
i
Rating by E. Leno at National Bank Financial
11/6/2017TD SecuritiesLower Price TargetHoldC$3.25 ➝ C$2.50
i
11/3/2017ScotiabankLower Price TargetOutperformC$6.00 ➝ C$4.25
i
11/2/2017Royal Bank of CanadaLower Price TargetOutperformC$5.00 ➝ C$4.50
i
9/25/2017ScotiabankLower Price TargetOutperformC$6.75 ➝ C$6.00
i
9/25/2017TD SecuritiesLower Price TargetHoldC$5.50 ➝ C$4.00
i
8/4/2017Royal Bank of CanadaLower Price TargetOutperformC$6.00 ➝ C$5.00
i
8/4/2017National Bank FinancialLower Price TargetSector Perform ➝ OutperformC$7.00 ➝ C$5.25
i
8/3/2017Beacon SecuritiesDowngradeBuy ➝ Hold
i
Rating by D. Cooper at Beacon Securities
8/3/2017National Bank FinancialLower Price TargetSector Perform ➝ OutperformC$7.00 ➝ C$5.25
i
Rating by E. Leno at National Bank Financial
8/3/2017ScotiabankLower Price TargetOutperformC$7.00 ➝ C$6.75
i
7/21/2017Royal Bank of CanadaLower Price TargetSector Perform ➝ OutperformC$8.50 ➝ C$6.00
i
7/18/2017TD SecuritiesBoost Price TargetBuy ➝ HoldC$5.50 ➝ C$10.00
i
7/17/2017National Bank FinancialLower Price TargetC$9.00 ➝ C$7.00
i
7/17/2017Royal Bank of CanadaBoost Price TargetSector PerformC$8.50 ➝ C$10.00
i
7/14/2017Bloom BurtonDowngradeBuy ➝ Accumulate
i
Rating by D. Martin at Bloom Burton
7/14/2017TD SecuritiesLower Price TargetBuyC$10.50 ➝ C$10.00
i
7/14/2017ScotiabankDowngradeOutperform ➝ Sector PerformC$10.00 ➝ C$8.00
i
7/7/2017TD SecuritiesLower Price TargetBuyC$12.00 ➝ C$10.50
i
4/28/2017TD SecuritiesReiterated RatingBuyC$12.00
i
4/28/2017Royal Bank of CanadaLower Price TargetSector PerformC$11.00 ➝ C$10.00
i
4/25/2017ScotiabankLower Price TargetOutperformC$10.25 ➝ C$9.75
i
3/16/2017Royal Bank of CanadaBoost Price TargetSector PerformC$9.50 ➝ C$11.00
i
3/8/2017TD SecuritiesBoost Price TargetBuyC$10.00 ➝ C$12.00
i
2/24/2017Bloom BurtonDowngradeBuy ➝ Accumulate
i
Rating by D. Martin at Bloom Burton
2/24/2017Beacon SecuritiesReiterated RatingBuy
i
Rating by D. Cooper at Beacon Securities
2/24/2017TD SecuritiesReiterated RatingBuyC$10.00
i
2/23/2017Royal Bank of CanadaReiterated RatingSector Perform
i
2/23/2017ScotiabankBoost Price TargetOutperformC$9.25 ➝ C$9.75
i
2/23/2017TD SecuritiesBoost Price TargetOutperformC$9.25 ➝ C$9.75
i
2/15/2017National Bank FinancialReiterated RatingSector PerformC$9.50
i
2/14/2017ScotiabankSet Price TargetOutperformC$9.25
i
2/2/2017ScotiabankReiterated RatingOutperformC$9.25
i
2/2/2017Royal Bank of CanadaBoost Price TargetC$8.50 ➝ C$9.00
i
1/30/2017TD SecuritiesReiterated RatingBuyC$10.00
i
1/30/2017Royal Bank of CanadaReiterated RatingSector PerformC$8.50
i
1/25/2017ScotiabankReiterated RatingOutperformC$9.25
i
11/28/2016Royal Bank of CanadaDowngradeOutperform ➝ Sector PerformC$7.00 ➝ C$8.50
i
11/28/2016Royal Bank of CanadaBoost Price TargetSector Perform ➝ OutperformC$7.00 ➝ C$8.50
i
10/28/2016Bloom BurtonReiterated RatingBuy
i
Rating by D. Martin at Bloom Burton
10/28/2016Royal Bank of CanadaBoost Price TargetC$6.50 ➝ C$7.00
i
10/6/2016Royal Bank of CanadaSet Price TargetOutperformC$6.50
i
10/6/2016Royal Bank of CanadaReiterated RatingOutperformC$6.50
i
9/13/2016CIBCReiterated RatingOutperform
i
(Data available from 5/16/2016 forward)
CRH Medical logo
CRH Medical Corporation provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers in the United States and Canada. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology to treat various grades of hemorrhoid. The company distributes CRH O'Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to gastroenterology practices. It also offers a hemorrhoid banding ancillary program, cybersecurity, and a consumer-centric digital application. The company was formerly known as Medsurge Medical Products Corp. and changed its name to CRH Medical Corporation in April 2006. CRH Medical Corporation was founded in 2000 and is headquartered in Vancouver, Canada. As of April 22, 2021, CRH Medical Corporation operates as a subsidiary of WELL Health Technologies Corp.
Read More

Today's Range

Now: N/A

50 Day Range

MA: C$4.95
C$4.82
C$5.04

52 Week Range

Now: N/A

Volume

36,924 shs

Average Volume

190,654 shs

Market Capitalization

C$357.38 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of CRH Medical?

The following Wall Street sell-side analysts have issued stock ratings on CRH Medical in the last twelve months: Bloom Burton, National Bank Financial, and Royal Bank of Canada.
View the latest analyst ratings for CRH.

What is the current price target for CRH Medical?

2 Wall Street analysts have set twelve-month price targets for CRH Medical in the last year. Their average twelve-month price target is C$5.05. National Bank Financial has the highest price target set, predicting CRH will reach C$5.10 in the next twelve months. Royal Bank of Canada has the lowest price target set, forecasting a price of C$5.00 for CRH Medical in the next year.
View the latest price targets for CRH.

What is the current consensus analyst rating for CRH Medical?

CRH Medical currently has 2 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CRH, but not buy more shares or sell existing shares.
View the latest ratings for CRH.

What other companies compete with CRH Medical?

How do I contact CRH Medical's investor relations team?

CRH Medical's physical mailing address is 57B - 999 Canada Place World Trade Center, VANCOUVER, BC V6C 3E1, Canada. The company's listed phone number is +1-604-6331440. The official website for CRH Medical is investors.crhsystem.com.